AU5492899A - The use of loop diuretics for hiv infection - Google Patents
The use of loop diuretics for hiv infectionInfo
- Publication number
- AU5492899A AU5492899A AU54928/99A AU5492899A AU5492899A AU 5492899 A AU5492899 A AU 5492899A AU 54928/99 A AU54928/99 A AU 54928/99A AU 5492899 A AU5492899 A AU 5492899A AU 5492899 A AU5492899 A AU 5492899A
- Authority
- AU
- Australia
- Prior art keywords
- hiv infection
- loop diuretics
- diuretics
- loop
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13839798A | 1998-08-24 | 1998-08-24 | |
US09138397 | 1998-08-24 | ||
PCT/US1999/018931 WO2000010574A1 (en) | 1998-08-24 | 1999-08-20 | The use of loop diuretics for hiv infection |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5492899A true AU5492899A (en) | 2000-03-14 |
Family
ID=22481821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54928/99A Abandoned AU5492899A (en) | 1998-08-24 | 1999-08-20 | The use of loop diuretics for hiv infection |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5492899A (en) |
WO (1) | WO2000010574A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1414863A (en) * | 1999-12-30 | 2003-04-30 | 亨德森莫利研究和开发有限公司 | Treatment of DNA viral infections |
GB2367242B (en) * | 2000-09-21 | 2004-07-28 | Henderson Morley Res & Dev Ltd | Antiviral treatment |
-
1999
- 1999-08-20 AU AU54928/99A patent/AU5492899A/en not_active Abandoned
- 1999-08-20 WO PCT/US1999/018931 patent/WO2000010574A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000010574A9 (en) | 2000-07-06 |
WO2000010574A1 (en) | 2000-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1939799A (en) | Anti-retroviral immunogens, preparation and use | |
AU7973994A (en) | Combination therapy for hiv infection | |
AU3118200A (en) | Hiv integrase inhibitors | |
AU1285300A (en) | Hiv vaccine | |
AU2759800A (en) | Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils | |
AU2001269704A1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
AU1408300A (en) | Hiv infection inhibitors | |
AU1534195A (en) | Quinazoline-2,4-diones | |
AU642751B2 (en) | New embodiments of the HIV principal neutralizing determinant | |
AU6704198A (en) | Surgical shoulder drape | |
AU6445798A (en) | Feline immunodeficiency virus clone jsy3 | |
AU2381995A (en) | Methanol derivatives for treatment of retroviral infections especially hiv infections | |
AU1260297A (en) | Flat sling coupling constructions | |
AU2473695A (en) | Method of slowing the progression of hiv infection | |
AU5492899A (en) | The use of loop diuretics for hiv infection | |
AU3714800A (en) | Hiv therapy | |
AU6130194A (en) | 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections | |
AU3086800A (en) | Injection-administered antiviral preparation | |
AU3698199A (en) | Radioimmuno-pharmacon for treating the hiv-1 infection | |
AU1979397A (en) | Peptidomimetics for the treatment of hiv infection | |
AU5274099A (en) | Hiv vaccine | |
AUPP561098A0 (en) | Measurement of persistent-latent HIV viral load | |
AU5982199A (en) | Process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds | |
AU8035098A (en) | Cephalosporin compounds, use thereof and intermediate compounds of the same | |
AU3196000A (en) | 3,3'-diketotrehalose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |